---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-002863"
form_type: "8-K"
ticker: "OACC"
cik: "0002029769"
company_name: "Oaktree Acquisition Corp. III Life Sciences"
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T09:24:52.518073+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Oaktree Acquisition Corp III board changes: Frank resigns, Kumar chairman, Pardesi appointed director

## Summary
- John Frank resigned from the board effective Jan 6, 2025, not due to any disagreement with the company.
- Aman Kumar, an existing director, was appointed as the new chairman of the board.
- CEO Zaid Pardesi was appointed as a Class III director, term expiring at third annual shareholder meeting.
- Pardesi and Kumar have material interests in the Sponsor Oaktree Acquisition Holdings III LS, as previously disclosed in the IPO prospectus.
- No arrangements or family relationships exist between Pardesi and other directors or executive officers.

## SEC filing metadata
- accession: 0001193125-25-002863
- form_type: 8-K
- ticker: OACC
- cik: 0002029769
- company_name: Oaktree Acquisition Corp. III Life Sciences
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/d920585d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-002863
- JSON: https://secwatch.observer/filing/0001193125-25-002863.json
- Plain text: https://secwatch.observer/filing/0001193125-25-002863.txt

## Key facts
- Executive change
  John Frank resigned as director at Oaktree Acquisition Corp. III Life Sciences.
  - Action: resigned
  - Role: director
  source text: On January 6, 2025, John Frank resigned from the board of directors (the “Board”) of Oaktree Acquisition Corp. III Life Sciences (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm
- Executive change
  Aman Kumar was appointed as chairman of the board at Oaktree Acquisition Corp. III Life Sciences.
  - Action: appointed
  - Role: chairman of the board
  source text: the Board appointed (i) Aman Kumar, currently a director of the Company, as the new chairman of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm
- Executive change
  Zaid Pardesi was appointed as director at Oaktree Acquisition Corp. III Life Sciences.
  - Action: appointed
  - Role: director
  source text: and (ii) Zaid Pardesi, the Company’s Chief Executive Officer, as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.